Delivery Order SPE2DB22D2206-SPE2DB25FEY41
Award Date
1/3/25
Potential Completion Date
1/6/25
Potential Value
$5.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $10,076.73, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RINVOQ ER 15 MG TABLET, a pharmaceutical product, with a completion date of November 25, 2024. The contract is a Delivery Order under a Firm Fixed Price arrangement, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite...
This federal contract award, valued at $12,813.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product, with an ultimate completion date of November 4, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This award is not designated as a set-aside contract....
The federal contract award of $13,651.77 was issued by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of RINVOQ ER 30 MG TABLET UU 30S, a pharmaceutical product, with a completion date of December 5, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. There is no set-aside designation for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distributor. The $14,910.27 firm fixed-price contract is for the supply of RINVOQ ER 15 MG TABLET UU 30S, a prescription medication. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, under which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,156.90 firm fixed-price delivery order is for RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of August 6, 2024. This award is a child contract under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,637.28, is for the delivery of RINVOQ ER 30 MG TABLET in quantities of 30 each. This is a Firm Fixed Price delivery order contract with a completion date of December 13, 2024. The contract is not designated as a set-aside and represents an open competition award. AmerisourceBergen Drug Corp,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The contract has a potential value of $27,175.99 and a completion date of March 1, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is issued under an indefinite delivery contract (IDC) valued at up to $999,999,999.00...
This federal contract award, valued at $24,652.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of RINVOQ ER 15 MG TABLET, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of May 21, 2024. The award is not associated with any set-aside requirements, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of RINVOQ ER 45 MG TABLET. The contract, valued at $13,727.88, is a firm-fixed price delivery order with an ultimate completion date of August 1, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $26,586.23 firm fixed-price delivery order is for the supply of RINVOQ ER 15 MG TABLET, a prescription medication. The contract has an ultimate completion date of October 10, 2024 and is not set aside for any specific business category. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...